Your browser doesn't support javascript.
loading
Cucurbitacin B inhibits non-small cell lung cancer in vivo and in vitro by triggering TLR4/NLRP3/GSDMD-dependent pyroptosis.
Yuan, Renyikun; Zhao, Wentong; Wang, Qin-Qin; He, Jia; Han, Shan; Gao, Hongwei; Feng, Yulin; Yang, Shilin.
Afiliação
  • Yuan R; College of Pharmacy, Jiangxi University of Traditional Chinese Medicine, Nanchang 330004, China; College of Pharmacy, Guangxi University of Chinese Medicine, Nanning 530000, China.
  • Zhao W; College of Pharmacy, Jiangxi University of Traditional Chinese Medicine, Nanchang 330004, China; College of Pharmacy, Guangxi University of Chinese Medicine, Nanning 530000, China.
  • Wang QQ; College of Pharmacy, Guangxi University of Chinese Medicine, Nanning 530000, China; Guangxi Engineering Technology Research Center of Advantage Chinese Patent Drug and Ethnic Drug Development, Nanning 530020, China.
  • He J; College of Pharmacy, Guangxi University of Chinese Medicine, Nanning 530000, China; Guangxi Engineering Technology Research Center of Advantage Chinese Patent Drug and Ethnic Drug Development, Nanning 530020, China.
  • Han S; College of Pharmacy, Guangxi University of Chinese Medicine, Nanning 530000, China; Guangxi Engineering Technology Research Center of Advantage Chinese Patent Drug and Ethnic Drug Development, Nanning 530020, China.
  • Gao H; College of Pharmacy, Guangxi University of Chinese Medicine, Nanning 530000, China; Guangxi Engineering Technology Research Center of Advantage Chinese Patent Drug and Ethnic Drug Development, Nanning 530020, China. Electronic address: gaohongwei06@126.com.
  • Feng Y; College of Pharmacy, Jiangxi University of Traditional Chinese Medicine, Nanchang 330004, China; State Key Laboratory of Innovative Drug and Efficient Energy-Saving Pharmaceutical Equipment, Jiangxi University of Traditional Chinese Medicine, Nanchang 330004, China. Electronic address: fengyulin2003
  • Yang S; College of Pharmacy, Guangxi University of Chinese Medicine, Nanning 530000, China; Guangxi Engineering Technology Research Center of Advantage Chinese Patent Drug and Ethnic Drug Development, Nanning 530020, China.
Pharmacol Res ; 170: 105748, 2021 08.
Article em En | MEDLINE | ID: mdl-34217831
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Triterpenos / Carcinoma Pulmonar de Células não Pequenas / Proteínas de Ligação a Fosfato / Receptor 4 Toll-Like / Proteínas Citotóxicas Formadoras de Poros / Inflamassomos / Piroptose / Proteína 3 que Contém Domínio de Pirina da Família NLR / Neoplasias Pulmonares / Antineoplásicos Fitogênicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Triterpenos / Carcinoma Pulmonar de Células não Pequenas / Proteínas de Ligação a Fosfato / Receptor 4 Toll-Like / Proteínas Citotóxicas Formadoras de Poros / Inflamassomos / Piroptose / Proteína 3 que Contém Domínio de Pirina da Família NLR / Neoplasias Pulmonares / Antineoplásicos Fitogênicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article